Industry
Biotechnology
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Loading...
Open
68.90
Mkt cap
656M
Volume
13K
High
70.59
P/E Ratio
-7.68
52-wk high
98.00
Low
68.01
Div yield
N/A
52-wk low
30.00
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.